These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10932030)

  • 1. Results and clinical implications of the CAPARES trial.
    Thaulow E; Jorgensen B
    Can J Cardiol; 2000 Jul; 16 Suppl D():8D-11D. PubMed ID: 10932030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Vatne K; Hansen J; Webb J; Buller C; Goulet G; Erikssen J; Thaulow E
    J Am Coll Cardiol; 2000 Mar; 35(3):592-9. PubMed ID: 10716459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.
    Thaulow E; Jorgensen B; Doyle JJ; Casciano R; Casciano J; Kopp Z; Arikian S; Kim R
    Int J Cardiol; 2002 Jul; 84(1):23-30; discussion 30-2. PubMed ID: 12104059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS.
    Folland ED; Hartigan PM; Parisi AF
    J Am Coll Cardiol; 1997 Jun; 29(7):1505-11. PubMed ID: 9180111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacoeconomic evaluation of amlodipine usage in patients undergoing PTCA in the US using results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES).
    Thaulow E; Jorgensen B; Doyle JJ; Casciano R; Casciano J; Arikian S; Kim R; Arocho R; Kopp Z
    J Cardiovasc Manag; 2001; 12(2):31-5. PubMed ID: 11299932
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
    Dens J; Desmet W; Piessens J
    Am Heart J; 2003 Mar; 145(3):404-8. PubMed ID: 12660661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary angioplasty in postinfarct angina].
    Buonanno C; Dander B; Variola A; Albiero R; Scazzina L
    G Ital Cardiol; 1992 Jun; 22(6):671-81. PubMed ID: 1426804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty.
    Klinge R; Jørgensen B; Thaulow E; Sirnes PA; Hall C
    Int J Cardiol; 1999 Jan; 68(1):1-8. PubMed ID: 10077394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.
    Rossetti F; De Portu S; Menditto E; Scalone L; Bustacchini S; Cricelli C; Mantovani LG
    Pharmacol Res; 2006 Mar; 53(3):197-201. PubMed ID: 16406672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.
    Parisi AF; Folland ED; Hartigan P
    N Engl J Med; 1992 Jan; 326(1):10-6. PubMed ID: 1345754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.
    Pitt B; Byington RP; Furberg CD; Hunninghake DB; Mancini GB; Miller ME; Riley W
    Circulation; 2000 Sep; 102(13):1503-10. PubMed ID: 11004140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Am J Cardiol; 2001 Jan; 87(1):28-33. PubMed ID: 11137829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcome.
    Gershlick A; Brack MJ; More RS; Syndercombe-Court D; Balcon R
    Coron Artery Dis; 1993 Jan; 4(1):73-81. PubMed ID: 8269186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).
    Mancini GB; Pitt B
    Am J Cardiol; 2002 Oct; 90(7):776-8. PubMed ID: 12356398
    [No Abstract]   [Full Text] [Related]  

  • 18. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
    Shang QH; Xu H; Lu XY; Wen C; Shi DZ; Chen KJ
    Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty. Significance of yellow plaque.
    Itoh A; Miyazaki S; Nonogi H; Daikoku S; Haze K
    Circulation; 1995 Mar; 91(5):1389-96. PubMed ID: 7867178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.
    Brener SJ; Ivanc TB; Poliszczuk R; Chen M; Tuzcu EM; Hu T; Frid DJ; Nissen SE
    Am Heart J; 2006 Dec; 152(6):1059-63. PubMed ID: 17161053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.